Table 1.
Demographic information of participants
| Tai Chi Group (n = 32) | Brisk Walking Group (n = 31) | Control Group (n = 32) | P value | |
|---|---|---|---|---|
| Sex, female, n (%) | 15 (46.88) | 9 (29.41) | 13 (41.18) | 0.500 |
| Age at baseline (mean ± SD) | 62.7 (5.51) | 61.9 (5.64) | 61.9 (6.76) | 0.400 |
| Education, years (mean ± SD) | 13.60 (2.71) | 13.10 (2.57) | 12.40 (2.83) | 0.472 |
| History of hypertension, n (%) | 7 (21.88) | 3 (11.76) | 5 (17.65) | 0.800 |
| History of diabetes mellitus, n (%) | 1 (3.13) | 0 (0.00) | 1 (3.13) | 1.000 |
| History of smoking, n (%) | 2 (6.25) | 2 (6.25) | 2 (6.25) | 0.600 |
| Family history, n (%) | 8 (25.00) | 5 (17.65) | 3 (11.76) | 0.600 |
| Tremor dominant, n (%) | 22 (68.75) | 22 (64.71) | 17 (58.82) | 0.800 |
| Disease duration (mean ± SD) | 5.91 (4.01) | 3.82 (1.87) | 4.32 (2.46) | 0.082 |
| Hoehn-Yahr staging, n (%) | 0.097 | |||
| 1.0 | 9 (28.13) | 8 (25.81) | 1 (3.13) | |
| 1.5 | 5 (15.63) | 7 (22.58) | 11 (34.38) | |
| 2.0 | 13 (40.63) | 13 (41.94) | 13 (40.63) | |
| 2.5 | 5 (15.63) | 3 (9.68) | 7 (21.88) | |
| LEDD at baseline (mean ± SD) | 326 (197) | 260 (174) | 347 (109) | 0.800 |
| ΔLEDD (mean ± SD) | 56.33 (91.68) | 39.71 (83.30) | 57.21 (107.24) | 0.939 |
LEDD levodopa equivalent daily dosage; N number; SD standard deviation
ΔLEDD LEDD at 12 months minus LEDD at baseline